CT-defined sarcopenia predicts treatment response in primary central nervous system lymphomas.
Alexey SurovHans Jonas MeyerMattes HinnerichsVincenzo FerraroVanja ZeremskiDimitrios MougiakakosSylvia SaalfeldAndreas WienkeAlexandra StrobelDenise WolleschakPublished in: European radiology (2023)
• Low skeletal muscle mass is strongly associated with the objective response rate. • No body composition parameters could predict dose-limiting toxicity.